Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma

Journal of Asthma

Volumn 34, Issue 3, 1997, Pages 227-234

  Mahajan, Puneet ^a   Okamoto, Lynn J ^a   Schaberg, Amy ^a   Kellerman, Don ^a   Schoenwetter, William F ^b  

^a GLAXOSMITHKLINE   (United States)

^b PARK NICOLLET INSTITUTE   (United States)

Author keywords

Asthma; Fluticasone propionate; Quality of life

Indexed keywords

ANTIASTHMATIC AGENT; FLUTICASONE PROPIONATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH STATUS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 0030977161     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909709068193     Document Type: Article

References (28)

1. Hume KM, Rhys Jones E: Bronchodilators and corticosteroids in asthma: Forced expiratory volume as an aid to diagnosis and treatment. Lancet 2:1319-1322 (1960).
2. Busse WW, Wilson AF: Task force on guidelines for clinical investigation of nonbronchodilator anti- asthmatic drugs: Assessment of efficacy. J Allergy Clin Immunol 78:525-528 (1986).
3. Juniper FE, Daniel EE, Robert RS, Kline PA, Hargreave FE, Newhouse MT: Improvement in airway responsiveness and clinical asthma severity during pregnancy. Am Rev Respir Dis 140:924-931 (1989).
4. Ware JE: Conceptualizing disease impact and treatment outcomes. Cancer 53(Suppl):2316-2326 (1984).
5. Wenger NK: Quality-of-Life considerations in new drug development. QOL Cardiovasc Care Autumn:128-130 (1988).
6. Ware JE: SF-36 Health Survey: Manual and Interpretation Guide, New England Medical Center, Boston, 1993.
7. Ware JE: Conceptualizing and measuring generic health outcomes. Cancer 67(Suppl):774-779 (1991).
8. Hyland ME: The Living with Asthma Questionnaire. Respir Med 85(Suppl B):13-16 (1991).
9. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE: Measuring quality of life in asthma. Am Rev Respir Dis 147:832-838 (1993).
10. Conclusions and Recommendations. Med Care 31(2)(Suppl):MS4-MS8 (1993).
11. Harding SM: The human pharmacology of fluticasone propionate. Respir Med 84(Suppl A): 25-29 (1990).
12. Chervinsky P, van As A, Bronsky EA, et al: Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 94:676-683 (1994).
13. Noonan M, Chervinsky P, Busse WW, et al: Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 152(5):1467-1473 (1995).
14. Okamoto LJ, Noonan M, De Boisblanc BP, Kellerman DJ: Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids. Ann Allergy Asthma Immunol 1996 (in press).
15. Richards JM, Hemstreet MP: Measures of life quality, role performance, and functional status in asthma research. Am J Respir Crit Care Med 149(2 Pt 2):S31-S39 (1994).
16. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-244 (1987).
17. Hyland ME, Kenyon CAP, Jacobs PA: Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics. QOL Res 3:121-126 (1994).
18. Hyland ME, Finnis S., Irvine SH: A scale for assessing quality of life in adult asthma sufferers. J Pyschosom Res 35(1):99-110 (1991).
19. Boyer G, Aaronson D, Meltzer E, Laforce C, Grossman J, Yancey S: Enhancement of a general quality of life scale: Validation of a sleep scale. J Allergy Clin Immunol 89(Suppl 1, part 2):186 (1992).
20. Hays RD, Hayashi T, Carson S, Ware JE: User's Guide for the Multitrait Analysis Program (MAP), A Rand Note, November 1988.
21. Pearlman D, Noonan M, Tashkin D, et al: Efficacy of inhaled fluticasone propionate (FP) powder in asthma. J Allergy Clin Immunol 95(1, pt 2):313 (1995) (abstract 690).
22. Viramontes JL, O'Brien B: Relationship between symptoms and health-related quality of life in chronic lung disease. J Gen Intern Med 9(1):46-48 (1994).
23. Palmer JBD, Hyland ME: Salmeterol in clinical practice: Comparator and safety studies, quality of life studies. Eur Respir Rev 1(4):301-303 (1991).
24. Martin RJ: Nocturnal asthma: Circadian rhythms and therapeutic interventions. Am Rev Respir Dis 147:S25- S28 (1993).
25. Turner-Warwick M: Epidemiology of nocturnal asthma. Am J Med 85:6-8 (1988).
26. Wasserman SI, Gross GN, Schoenwettter WF, Munk ZM, Kral KM: A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. J Asthma (1996) 33:4 265-274 (1996).
27. Hummel S, Lehtonen L: Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroids in maintenance treatment of severe asthma. Lancet 340:1483-1487 (1992).
28. Gaddie J, Reid IW, Skinner C, et al: Aerosol beclomethasone dipropionate: A dose-response study in chronic bronchial asthma. Lancet 2:280-281 (1973).